How Tools And Technologies Bring Advanced Therapies To Market
Source: Cytiva
Featuring Clive Glover, General Manager, Gene Therapy, at Pall, and James Taylor, co-founder and GM, Precision NanoSystems
![Molecular Genetic Therapy iStock-1289215513 Molecular Genetic Therapy iStock-1289215513](https://vertassets.blob.core.windows.net/image/7815a4ca/7815a4ca-75d3-4207-bcf5-f9d21223eb95/375_250-molecular_genetic_therapy_istock_1289215513.jpg)
Clive Glover, General Manager, Gene Therapy, at Pall and James Taylor, co-founder and GM, Precision NanoSystems, discuss how their combined expertise can help drug developers get exciting genomic medicines to patients.
access the Q&A!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more